Although the reason for these false negative results is difficult to definitively determine, potential reasons include: (1) intratumoral heterogeneity of MLH1 methylation where different areas of the tumor were tested by the pathology labs and by the study, and (2) the sensitivity of MLH1 methylation detection is likely different between different assays. This evidence concerns the gene MLH1 and neoplasm.